This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa
The drug UPTRAVI contains one active pharmaceutical ingredient (API):
1
Selexipag
UNII 5EXC0E384L - SELEXIPAG
|
Selexipag is a selective IP receptor agonist distinct from prostacyclin and its analogues. Selexipag is hydrolysed by carboxylesterases to yield its active metabolite, which is approximately 37-fold more potent than selexipag. Stimulation of the IP receptor by selexipag and the active metabolite leads to vasodilatory as well as anti-proliferative and anti-fibrotic effects. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
UPTRAVI Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B01AC27 | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 12235Y, 12240F, 12241G, 12242H, 12245L, 12246M, 12247N, 12248P, 12249Q, 12251T, 12252W, 12253X, 12257D, 12258E, 12259F, 12260G, 12263K, 12264L, 12265M, 12266N |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 514519120034617, 514519120034717, 514519120034817, 514519120034917, 514519120035017, 514519120035117, 514519120035217, 514519120035317, 514519120035417 |
Country: CA | Health Products and Food Branch | Identifier(s): 02451158, 02451166, 02451174, 02451182, 02451190, 02451204, 02451212, 02451220 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 5210-MEE-0720, 5211-MEE-0720, 5212-MEE-0720, 5213-MEE-0720, 5217-MEE-0720, 5218-MEE-0720, 5219-MEE-0720, 5220-MEE-0720 |
Country: EE | Ravimiamet | Identifier(s): 1718962, 1718973, 1718984, 1719008, 1719019, 1719020, 1719031, 1719042, 1719053, 1719064 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1151083002, 1151083004, 1151083005, 1151083006, 1151083007, 1151083008, 1151083009, 1151083010 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 035514, 076740, 080632, 158281, 390548, 463311, 484594, 562401, 598861 |
Country: FR | Base de données publique des médicaments | Identifier(s): 61050007, 61387896, 62611475, 63092880, 63817001, 64003920, 66157358, 67667620 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 329637, 329639, 329643, 329647, 329651, 329655, 329659, 329663, 329676 |
Country: HK | Department of Health Drug Office | Identifier(s): 65584, 65585, 65586, 65587, 65588, 65589, 65590, 65591 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 88975, 88976, 88977, 88978, 88979, 88980, 88981, 88982, 88983 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8030, 8031, 8032, 8033, 8034, 8035, 8036, 8037, 8038 |
Country: IT | Agenzia del Farmaco | Identifier(s): 044887014, 044887026, 044887038, 044887040, 044887053, 044887065, 044887077, 044887089, 044887091, 044887103, 044887115 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2190037F1020, 2190037F2027 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1080382, 1080383, 1080384, 1080385, 1080386, 1080387, 1080388, 1080389, 1080390, 1080391, 1083721 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 134260, 134279, 134287, 134295, 134309, 134317, 134325, 134333 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 17455, 17456, 17457, 17458, 17459, 17460, 17461, 17465 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100372187, 100372201, 100372218, 100372224, 100372247, 100372253, 100372260, 100372276 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67358001, W67358002, W67358003, W67359001, W67360001, W67361001, W67362001, W67363001, W67364001, W67365001 |
Country: SG | Health Sciences Authority | Identifier(s): 15283P, 15284P, 15285P, 15286P, 15287P, 15288P, 15289P, 15290P |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699593095498, 8699593095504, 8699593095511, 8699593095528, 8699593095535, 8699593095542, 8699593095559, 8699593095566, 8699593095573 |
Country: US | FDA, National Drug Code | Identifier(s): 66215-602, 66215-604, 66215-606, 66215-608, 66215-610, 66215-612, 66215-614, 66215-616 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 53/7.1.3/0631, 53/7.1.3/0632, 53/7.1.3/0633, 53/7.1.3/0634, 53/7.1.3/0635, 53/7.1.3/0636, 53/7.1.3/0637, 53/7.1.3/0638 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.